Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Blog Post | Timely Disclosure

COVID-19 and Material Adverse Change Provisions in M&A Agreements

Fasken
Reading Time 1 minute read
Subscribe
Introduction The COVID-19 pandemic has raised a fundamental question for M&A participants: does the outbreak of COVID-19 and the impact on a business constitute a “Material Adverse Change” (referred to as a “MAC”) under merger agreements? The answer is important because if the pandemic is a MAC, then buyers can typically walk away from a... Continue Reading

    Subscribe

    Receive email updates from our team

    Subscribe